Dexcom gives CFO Jereme Sylvain expanded role
Article excerpt
Highlighted: the sentence this signal was extracted from
Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO. Name: Jereme Sylvain New title: Chief operating officer and CFO, Dexcom Previous title: CFO, Dexcom Dexcom said Monday it has made Jereme Sylvain chief operating officer, expanding the executive's role at the diabetes technology company. Sylvain joined Dexcom in 2018 and became CFO in 2021. By expanding Sylvain's role, Dexcom has filled a vacancy created by the promotion of Jake Leach to CEO at the start of 2026. Leach served as president and COO before replacing Kevin Sayer as CEO. Sayer and Leach both worked as Dexcom COO before becoming CEO. Dexcom named Sayer COO in 2013 and promoted him to CEO in 2015. Leach, who joined Dexcom in 2004, became COO in 2022 and rose to the top job in 2026. Like his predecessors, Sylvain will oversee global operations as COO. Dexcom has tasked the promoted executive with driving greater alignment, speed and accountability across the company. Sylvain secured the expanded responsibilities after showing "the ability to align and execute cross-functionally" during his time at the company, Dexcom said. "His deep understanding of our business, operational discipline and customer focus make him the right leader for this expanded role," Leach said in a statement. "I am confident that Jereme will help us scale more effectively as we advance...
Keep reading with a free account
The rest of this article, and every signal for Dexcom, is in your free account.
